The company has an investment team with over 40 years of experience across the healthcare industry. Its team includes senior leaders with expertise in drug discovery, research and development, drug manufacturing, business development and licensing, and investment fund management.
3B FUTURE Health Fund (3B FUTURE Health Fund II S.C.A. SICAV-RAIF, c/o Intertrust Group, 6 rue Eugène Ruppert, L-2453 Luxembourg, Grand Duchy of Luxembourg) is advised by 3B FUTURE Health Ventures SARL.
The company draws on its expertise and network to bring oncology treatments to patients.
3B Future Health Fund
3B Future Health Fund, a Luxembourg-based investment firm, focuses on early-stage investments in innovative companies addressing high unmet patient needs, particularly in the rare disease and oncology sectors. The fund primarily supports US and European-based private companies and typically participates in Seed, Series A, B, C, and D rounds. Their investment strategy emphasizes leveraging scientific expertise and a robust network to discover and develop life-changing therapies.
